Product Description
2.5 MG Bortezomib Injection IP is a liquid dosage form used for the treatment of multiple myeloma and mantle cell lymphoma. It is manufactured in India and has a shelf life of 24-36 months. The fermentation smell is normal, and it should be stored at a temperature of 20C to 25C or 68F to 77F. This injection is a proteasome inhibitor that works by preventing the growth and division of cancer cells. It is administered by a healthcare professional through injection into a vein.
FAQs of 2.5 MG Bortezomib Injection IP:
Q: What is the use of 2.5 MG Bortezomib Injection IP?
A: 2.5 MG Bortezomib Injection IP is used for the treatment of multiple myeloma and mantle cell lymphoma.
Q: How should 2.5 MG Bortezomib Injection IP be stored?
A: It should be stored at a temperature of 20C to 25C or 68F to 77F.
Q: How is 2.5 MG Bortezomib Injection IP administered?
A: It is administered by a healthcare professional through injection into a vein.
Q: What is the shelf life of 2.5 MG Bortezomib Injection IP?
A: It has a shelf life of 24-36 months.
Q: What is the mode of action of 2.5 MG Bortezomib Injection IP?
A: 2.5 MG Bortezomib Injection IP is a proteasome inhibitor that works by preventing the growth and division of cancer cells.